Physician profile
Amy Mertens
NPI 1235544966
$14,537.38
in general payments reported to CMS, 2019-2025
19 companies · $7,950 in 2025
The $7,950 reported for 2025 was more than what 87% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2021: $2,000 · 2022: $2,349 · 2023: $753 · 2024: $1,338 · 2025: $7,950.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,323 · Travel and Lodging: $3,513 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,200 · Education: $6.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,322.55 |
| Travel and Lodging | $3,512.79 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,200.00 |
| Education | $6.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $7,903.59 | 2021-2025 | Coroflow, Pressurewire |
| Boston Scientific Corporation | $1,867.52 | 2021-2025 | General - Therapies, Synergy, Avvigo Guidance System |
| Abiomed | $1,477.18 | 2021-2025 | Impella |
| Medtronic, INC. | $732.38 | 2024-2025 | Resolute Onyx, Symplicity G3, Linq II |
| Shockwave Medical, INC | $689.23 | 2021-2025 | |
| Asahi Intecc USA, INC. | $637.88 | 2022-2025 | Asahi Coronary Wires, Asahi Ptca Guide Wire, Peripheral Vascular |
| Teleflex LLC | $318.44 | 2024-2025 | Turnpike, Guideliner |
| Verge Medical, INC. | $310.67 | 2024 | |
| Acist Medical Systems, INC. | $147.07 | 2019 | |
| Inari Medical, INC. | $105.12 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $81.53 | 2022 | |
| Novartis Pharmaceuticals Corporation | $62.82 | 2025 | |
| Amgen INC. | $50.06 | 2025 | Repatha |
| Alnylam Pharmaceuticals INC. | $39.73 | 2025 | Amvuttra |
| Novo Nordisk INC | $29.14 | 2025 | Wegovy |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $25.68 | 2024 | Alphavac |
| Bayer Healthcare Pharmaceuticals INC. | $23.33 | 2025 | |
| Pfizer INC. | $20.76 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.25 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Mertens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.